"Designing Growth Strategies is in our DNA"

Anticoagulation Monitoring Devices Market Size, Share & Industry Analysis, By Device Type (PT-INR Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPTT)), By End-user (Hospitals & Clinics, Homecare, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113537

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases in Key Countries
    2. New Product Launches, By Key Players
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    4. Technological Advancements in Anticoagolation Monitoring Devices
  5. Global Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa 
  6. North America Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. S.
      2. Canada
  7. Europe Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europ 
  8. Asia Pacific Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America 
  10. Middle East & Africa Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Werfen
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Helena Diagnostics Corporation
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Abbott
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Hoffmann-La Roche AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Siemens Healthineers AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Koninklijke Philips N.V.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. HORIBA, Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sysmex
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Other Prominent Players
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases in Key Countries
    2. New Product Launches, By Key Players
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
    4. Technological Advancements in Anticoagolation Monitoring Devices
  5. Global Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa 
  6. North America Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. S.
      2. Canada
  7. Europe Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europ 
  8. Asia Pacific Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America 
  10. Middle East & Africa Anticoagolation Monitoring Devices Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Device Type
      1. PT-INR Testing Devices
      2. Activated Clotting Time (ACT)
      3. Activated Partial Thromboplastin Time (aPTT)
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals & Clinics
      2. Homecare
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Werfen
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Helena Diagnostics Corporation
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Abbott
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Hoffmann-La Roche AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Siemens Healthineers AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Koninklijke Philips N.V.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. HORIBA, Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Sysmex
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Other Prominent Players
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Anticoagulation Monitoring Devices Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global Anticoagulation Monitoring Devices Market Value Share (%), by Device Type, 2024 & 2032

Figure 3: Global Anticoagulation Monitoring Devices Market Value Share (%), by End-user, 2024 & 2032

Figure 4: Global Anticoagulation Monitoring Devices Market Value Share (%), by Region, 2024 & 2032

Figure 5: North America Anticoagulation Monitoring Devices Market Value (USD billion), by Device Type, 2024 & 2032

Figure 6: North America Anticoagulation Monitoring Devices Market Value Share (%), by Device Type, 2024

Figure 7: North America Anticoagulation Monitoring Devices Market Value (USD billion), by End-user, 2024 & 2032

Figure 8: North America Anticoagulation Monitoring Devices Market Value Share (%), by End-user, 2024

Figure 9: North America Anticoagulation Monitoring Devices Market Value (USD billion), By Country, 2024 & 2032

Figure 10: North America Anticoagulation Monitoring Devices Market Value Share (%), By Country, 2024

Figure 11: Europe Anticoagulation Monitoring Devices Market Value (USD billion), by Device Type, 2024 & 2032

Figure 12: Europe Anticoagulation Monitoring Devices Market Value Share (%), by Device Type, 2024

Figure 13: Europe Anticoagulation Monitoring Devices Market Value (USD billion), by End-user, 2024 & 2032

Figure 14: Europe Anticoagulation Monitoring Devices Market Value Share (%), by End-user, 2024

Figure 15: Europe Anticoagulation Monitoring Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 16: Europe Anticoagulation Monitoring Devices Market Value Share (%), By Country/ Sub-region, 2024

Figure 17: Asia Pacific Anticoagulation Monitoring Devices Market Value (USD billion), by Device Type, 2024 & 2032

Figure 18: Asia Pacific Anticoagulation Monitoring Devices Market Value Share (%), by Device Type, 2024

Figure 19: Asia Pacific Anticoagulation Monitoring Devices Market Value (USD billion), by End-user, 2024 & 2032

Figure 20: Asia Pacific Anticoagulation Monitoring Devices Market Value Share (%), by End-user, 2024

Figure 21: Asia Pacific Anticoagulation Monitoring Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 22: Asia Pacific Anticoagulation Monitoring Devices Market Value Share (%), By Country/ Sub-region, 2024

Figure 23: Latin America Anticoagulation Monitoring Devices Market Value (USD billion), by Device Type, 2024 & 2032

Figure 24: Latin America Anticoagulation Monitoring Devices Market Value Share (%), by Device Type, 2024

Figure 25: Latin America Anticoagulation Monitoring Devices Market Value (USD billion), by End-user, 2024 & 2032

Figure 26: Latin America Anticoagulation Monitoring Devices Market Value Share (%), by End-user, 2024

Figure 27: Latin America Anticoagulation Monitoring Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 28: Latin America Anticoagulation Monitoring Devices Market Value Share (%), By Country/ Sub-region, 2024

Figure 29: Middle East & Africa Anticoagulation Monitoring Devices Market Value (USD billion), by Device Type, 2024 & 2032

Figure 30: Middle East & Africa Anticoagulation Monitoring Devices Market Value Share (%), by Device Type, 2024

Figure 31: Middle East & Africa Anticoagulation Monitoring Devices Market Value (USD billion), by End-user, 2024 & 2032

Figure 32: Middle East & Africa Anticoagulation Monitoring Devices Market Value Share (%), by End-user, 2024

Figure 33: Middle East & Africa Anticoagulation Monitoring Devices Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 34: Middle East & Africa Anticoagulation Monitoring Devices Market Value Share (%), By Country/ Sub-region, 2024

Figure 35: Global Anticoagulation Monitoring Devices Market Share (%), By Company, 2024

Table 1: Global Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 2: Global Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 3: Global Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 4: North America Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 5: North America Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 6: North America Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 7: Europe Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 8: Europe Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 9: Europe Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 10: Asia Pacific Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 11: Asia Pacific Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 12: Asia Pacific Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Latin America Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 14: Latin America Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 15: Latin America Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Middle East & Africa Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by Device Type, 2019–2032

Table 17: Middle East & Africa Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, by End-user, 2019–2032

Table 18: Middle East & Africa Anticoagulation Monitoring Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

  • 2019-2032
  • 2024
  • 2019-2023
  • 155
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann